Stock Price
76.92
Daily Change
1.17 1.54%
Monthly
-4.80%
Yearly
2.85%
Q1 Forecast
74.60

Solventum Corp reported $1.64B in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
Abbott USD 7.51B 560M Sep/2025
Align Technology USD 1B 103.43M Sep/2025
Baxter International USD 1.73B 40M Sep/2025
Becton, Dickinson and Co. USD 641M 94M Sep/2025
Cencora USD 1.75B 2.6B Dec/2025
Dexcom USD 1.84B 676.7M Sep/2025
Insulet USD 757.4M 364.2M Sep/2025
Solventum Corp USD 1.64B 1.15B Sep/2025
West Pharmaceutical Services USD 628.5M 118.8M Sep/2025
Zimmer Biomet Holdings USD 1.29B 735.8M Sep/2025